ArticleExperimental & molecular medicine2024

PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.

Gu-Choul Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.